Life Science Company News

Reset
Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 01 May 2024
Related companies:  Karyopharm Therapeutics Inc.

Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast

Read more ››
By: PR Newswire Association LLC. - 01 May 2024
Related companies:  Azenta US, Inc

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 01 May 2024
Related companies:  Akebia Therapeutics, Inc.

Emergency Departments Frequently Miss Signs of Epilepsy in Children

Read more ››
By: PR Newswire Association LLC. - 01 May 2024
Related companies:  NYU Langone Health | NYU Langone Medical Center- Cytometry & Cell Sorting Laboratory

Envista Reports First Quarter 2024 Results

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Encompass Health opens request for grant applications

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Remote Pregnancy Care Innovator Nuvo Group Ltd. Becomes Public Company Through Completion of Business Combination with LAMF Global Ventures Corp.

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Moonstone Nutrition Launches New Investment Opportunity on StartEngine to Fuel Company Growth and Prevent Painful Kidney Stones

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

El Camino Health Earns "A" Hospital Safety Rating from The Leapfrog Group

Read more ››
By: PR Newswire Association LLC. - 01 May 2024
Related companies:  Camino Pharma, LLC | Camino Real Capital Partners, LLC

Opioid Withdrawal Syndrome Drug Market to Surge at a CAGR of 4.0% by 2034 | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

EVP Capital Enters into Letter of Intent for a Proposed Qualifying Transaction

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  G1 Therapeutics, Inc.

G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  G1 Therapeutics, Inc.

Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn’s disease

Read more ››
By: GlobeNewswire - 01 May 2024

ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  ADC Therapeutics SA

Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Beyond Air, Inc.

Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Chimerix, Inc.

 Amarin Reports First Quarter 2024 Business Update and Financial Results

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Amarin Corporation plc

TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  TG Therapeutics, Inc.
Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »